Fraser AD - Search Results

1

Pollak PT, Mukherjee SD, Fraser AD. Pollak PT, et al. Among authors: fraser ad. Ann Pharmacother. 2001 Nov;35(11):1371-4. doi: 10.1345/aph.1Z431. Ann Pharmacother. 2001. PMID: 11724085

2

Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.

Kiberd BA, Puthenparumpil JJ, Fraser A, Tett SE, Lawen J. Kiberd BA, et al. Transplant Proc. 2005 Jun;37(5):2320-3. doi: 10.1016/j.transproceed.2005.03.059. Transplant Proc. 2005. PMID: 15964408 Clinical Trial.

3

New drugs for the treatment of epilepsy.

Fraser AD. Fraser AD. Clin Biochem. 1996 Apr;29(2):97-110. doi: 10.1016/0009-9120(95)02027-6. Clin Biochem. 1996. PMID: 8601332 Review.

4

Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.

Balbontin F, Kiberd B, Fraser A, Kiberd M, Lawen J. Balbontin F, et al. Clin Transplant. 2005 Apr;19(2):225-9. doi: 10.1111/j.1399-0012.2005.00325.x. Clin Transplant. 2005. PMID: 15740559

5

Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J. Mahalati K, et al. J Am Soc Nephrol. 2001 Apr;12(4):828-833. doi: 10.1681/ASN.V124828. J Am Soc Nephrol. 2001. PMID: 11274245

6

Tacrolimus monitoring by simplified sparse sampling under the concentration time curve.

Balbontin FG, Kiberd B, Squires J, Singh D, Fraser A, Belitsky P, Lawen J. Balbontin FG, et al. Transplant Proc. 2003 Nov;35(7):2445-8. doi: 10.1016/j.transproceed.2003.08.020. Transplant Proc. 2003. PMID: 14611982

7

Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience.

Singh D, Kiberd B, Belitsky P, Fraser A, Balbontin F, Lawen J. Singh D, et al. Transplant Proc. 2004 Mar;36(2 Suppl):414S-419S. doi: 10.1016/j.transproceed.2004.01.055. Transplant Proc. 2004. PMID: 15041377

8

Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation.

Balbontin F, Kiberd B, Singh D, Squires J, Fraser A, Belitsky P, Lawen J. Balbontin F, et al. Transplant Proc. 2003 Nov;35(7):2409-11. doi: 10.1016/j.transproceed.2003.08.005. Transplant Proc. 2003. PMID: 14611972

9

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation.

Kiberd BA, Lawen J, Fraser AD, Keough-Ryan T, Belitsky P. Kiberd BA, et al. Among authors: fraser ad. Am J Transplant. 2004 Jul;4(7):1079-83. doi: 10.1111/j.1600-6143.2004.00455.x. Am J Transplant. 2004. PMID: 15196064 Free article.

10

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.

McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS. McAlister VC, et al. Ther Drug Monit. 2002 Jun;24(3):346-50. doi: 10.1097/00007691-200206000-00004. Ther Drug Monit. 2002. PMID: 12021624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters